DIETARY LIPIDS--EFFECTS ON LIPID-LIPOPROTEIN METABOLISM
DIETARY LIPIDS--EFFECTS ON LIPID-LIPOPROTEIN METABOLISM
批准号:
3353892
负责人:
D ROGER ILLINGWORTH
金额:
$52.6万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-30 至 1991-11-30
关键词:
antihyperlipoproteinemic agent apolipoproteins blood chemistry blood lipoprotein metabolism cholesterol dietary lipid eicosanoid metabolism eicosanoids high density lipoproteins human subject hypercholesterolemia hypertriglyceridemia leukocytes lipid metabolism low density lipoprotein marine animal oil mevalonate nutrition education nutrition related tag omega 3 fatty acid platelets saturated fatty acids seafood sterols triglycerides unsaturated fatty acids urinalysis very low density lipoprotein
中文摘要
我们提出了一系列综合的临床和生化研究。
为了更好地描述特定膳食脂类对血脂和
受试者的脂蛋白代谢。饮食对人类健康的影响
单不饱和脂肪酸代表的主要脂肪来源将是
比较它们与同类产品的降脂效果
饮食中含有30%的热量来自omega-6多不饱和脂肪酸
或者主要是饱和脂肪酸,这两种脂肪酸都与低脂
节食。所有的饮食都将喂给患有原发性高胆固醇血症的受试者
有待研究的脂蛋白代谢参数包括
血、尿~(125)I-低密度脂蛋白转换率、胆固醇稳态的研究
新鲜分离的人甲伐他酸排泄与胆固醇合成
单核白细胞。这四种饮食将被喂给服用
无胆固醇饮食和每天600毫克的饮食
胆固醇。长链多不饱和脂肪的代谢效应
从鱼油中提取的酸将在项目概述的研究中进行检验
2.这些研究的目的是检查是否有降甘油三酯的作用
长链omega-3多不饱和脂肪酸主要是由于
二十碳五烯酸或二十二碳六烯酸
纯化的脂肪酸(作为饮食成分)可防止碳水化合物诱导
高甘油三酯血症。高密度脂蛋白降低的机制
喂食低胆固醇鱼的高胆固醇血症受试者的血药浓度
油将通过用125I标记的高密度脂蛋白进行动力学研究来检测。
鱼油对前列腺素形成的影响将在
合作研究。这些研究应该会增进我们的知识
关于长链omega-3脂肪的抗动脉粥样硬化作用
酸。甾醇对血脂和脂蛋白的影响
将检测正常和高胆固醇血症受试者的血药浓度。
饲料中添加海鲜类固醇。最后,第四个项目
旨在检查三个阶段的降胆固醇效果
在志愿者中谨慎饮食,建立食谱开发
实验室,并前瞻性地评估饮食的有效性
咨询作为长期控制血脂的辅助手段
门诊部。总体而言,这些研究应该会增进我们的知识
关于特定膳食脂肪的临床和代谢影响
并可直接应用于治疗
高胆固醇血症。
英文摘要
We propose an integrated series of clinical and biochemical investigations
to better delineate the effects of specific dietary lipids on lipid and
lipoprotein metabolism in human subjects. The influence of diets in which
monounsaturated fatty acids represent the main source of fat will be
investigated in terms of their lipid lowering effects compared to similar
diets containing 30% of calories from omega-6 polyunsaturated fatty acids
or primarily saturated fatty acids and both of these compared to a low fat
diet. All diets will be fed to subjects with primary hypercholesterolemia
and parameters of lipoprotein metabolism to be studied will include
125I-LDL turnover, cholesterol homeostasis assessed by serum and urinary
excretion of mevalonic acid and cholesterol synthesis in freshly isolated
mononuclear leukocytes. These four diets will be fed to subjects consuming
a cholesterol-free diet and in the presence of 600 mg/day of dietary
cholesterol. The metabolic effects of long chain polyunsaturated fatty
acids derived from fish oil will be examined in studies outlined in Project
2. These studies aim to examine whether the hypotriglyceridemic effects of
long-chain omega-3 polyunsaturated fatty acids are due primarily to
eicosapentaenoic acid or docosahexaenoic acid by determining if these
purified fatty acids (as dietary constituents) prevent carbohydrate induced
hypertriglyceridemia. The mechanisms responsible for the reduction of HDL
concentrations in hypercholesterolemic subjects fed a low cholesterol fish
oil will be examined by performing kinetic studies with 125I-labeled HDL.
The influence of fish oils on prostanoid formation will be examined in
collaborative studies. These studies should further our knowledge
concerning the anti-atherosclerotic effects of long chain omega-3 fatty
acids. The influence of sterols on plasma lipid and lipoprotein
concentrations will be examined in normal and hypercholesterolemic subjects
fed diets supplemented with seafood sterols. Finally, the fourth project
aims to examine the hypocholesterolemic effects of three phases of a
prudent diet in volunteer subjects, establish a recipe development
laboratory, and prospectively assess the effectiveness of dietary
counseling as an adjunct to long-term control of plasma lipids in an
outpatient setting. Overall, these studies should enhance our knowledge
concerning the clinical and metabolic effects of specific dietary lipids
and have direct therapeutic application to treatment of subjects with
hypercholesterolemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of simvastatin on postprandial hyperlipidemia
-
批准号:6465859
-
项目类别:
-
资助金额:$17.24万
-
财政年份:2000
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
REGULAR AND SUSTAINED RELEASE SIMVISTATIN IN HYPERCHOLESTEROLEMIA
-
批准号:6116977
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
SIMVASTATIN ON STEROID HORMONE PRODUCTION IN MEN WITH HYPERCHOLESTEROLEMIA
-
批准号:6116946
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
THE EFFECTS OF HIGH DOSE SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6116953
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
METABOLIC STUDY ON THE HYPOLIPIDEMIC EFFECTS OF DRUGS WHICH INHIBIT CHOLESTEROL
-
批准号:6116945
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
BAYW6228 COMPARED TO PLACEBO & LOVASTATIN IN PTS W/ PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6116950
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
LIPID METABOLISM IN ABETALIPOPROTEINEMIA
-
批准号:6116969
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
CHOLESTEROL REDUCTION WITH LDL APHERESIS IN HYPERCHOLESTEROLEMIA
-
批准号:6116920
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
EFFECTS OF ATORVASTATIN IN TYPE III HYPERLIPIDEMIA--OPEN EXTENSION STUDY
-
批准号:6116952
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
MULTICENTER TRIAL OF MEVINOLIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6116918
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
MULTICENTER STUDY OF MEVINOLIN VS CHOLESTYRAMINE IN HYPERCHOLESTEROLEMIA
-
批准号:6116916
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
U S/JAPAN CONFERENCE ON OXIDANTS AND ANTIOXIDANTS
-
批准号:2592895
-
项目类别:
-
资助金额:$4.0万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
EFFECTS OF GEMFIBROZIL, SIMVASTATIN, AND ATORVASTATIN IN TYPE III HYPERLIPIDEMIA
-
批准号:6248054
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
THE EFFECTS OF HIGH DOSE SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6248079
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
LIPID METABOLISM IN ABETALIPOPROTEINEMIA
-
批准号:6278164
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
MULTICENTER STUDY OF MEVINOLIN VS CHOLESTYRAMINE IN HYPERCHOLESTEROLEMIA
-
批准号:6278111
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
EFFECTS OF HIGH DOSE SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6248059
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
EFFECTS OF ATORVASTATIN IN TYPE III HYPERLIPIDEMIA--OPEN EXTENSION STUDY
-
批准号:6248078
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
MULTICENTER STUDY OF MEVINOLIN VS CHOLESTYRAMINE IN HYPERCHOLESTEROLEMIA
-
批准号:6248014
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
BAYW6228 COMPARED TO PLACEBO & LOVASTATIN IN PTS W/ PRIMARY HYPERCHOLESTEROLEMIA
-
批准号:6278145
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1997
-
负责人:D ROGER ILLINGWORTH
-
依托单位:
海外基金